Abstract
A marked loss of body weight and body protein, and a generalized wasting of skeletal muscle, frequently accompany infection, injury and certain neoplastic diseases (1, 2). These conditions result in a negative nitrogen balance, which may exceed that seen in fasting (2–9). This net nitrogen loss may result from increased degradation of cell protein, reduced rates of protein synthesis, or both (2–9). Skeletal muscle, which comprises a major body protein reserve, would appear to be a primary site for this catabolic response (2–9). Experimental infections, injury or tumours result in a marked loss of muscle mass, and enhancement of protein breakdown in muscle (2, 3, 7, 8). Similarly, in human patients, there is evidence of increased muscle proteolysis and net release of amino aids from this tissue (4, 10). However, the factor(s) initiating muscle catabolism have still to be fully characterized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beisel, W.R. 1984. Metabolic effects of infection. Prog. Food Nutr. Sci. 8:43-75.
DeWys, W.D. 1982. Pathophysiology of cancer cachexia. Cancer Res. 42: 7215-7265
Fagan, J.M., and A.L. Goldberg. 1985. Muscle protein breakdown, prostaglandin E2 production and fever following bacterial infection. In The Physiological. Metabolic and Immunologic Actions of Interleukin-1. (Kluger, M.J., J.J. Oppenheimer, and M.C. Powanda, editors). Alan R. Liss, New York, 201-210.
Clowes Jr., G.H.A., B.C. George, C.A. Vi11ee Jr., and C. Saravis. 1983. Muscle proteolysis induced by a circulating peptide in patients with trauma or sepsis. New Engl. J. Med. 308:.545-552.
Baracos, V.E., H.P. Rodemann, C.A. Dinare110, and A.L. Goldberg. 1983. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (Interleukin-1). New Engl. J. Med. 308:553-558.
Goldberg, A.L., Baracos, V., Rodemann, P., Waxman, L., and Dinare110, C. 1984. Control of protein degradation in muscle by prostaglandins, Ca2+ and leukocytic pyrogen (Interleukin-1) Fed. Proc. 43:1301-1306.
Ruff, R., and Secrist, D. 1984. Inhibitors of prostaglandin synthesis or cathepsin D prevent muscle wasting due to sepsis in the rat. J. Clin. Invest. 73:1483-1486.
Jepson, M., M. Pe11, P.C. Bates, and D.J. Millward. 1986. Effects of endotoxemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem. J. 235:329-336.
Moldawer, L.L. 1986. Interleukin-1 tumor necrosis factor-a (cachectin) and the pathogenesis of cancer cachexia. Ph.D. thesis, Dept. of Surgery, Goteborgs Universitet, Sweden.
Benegard, K. 1982. Metabolic balance across the leg in weight - losing cancer patients, Cancer res. 42: 4293 4298
Adams, D.O., T.A. Hamilton. 1984. The cell biology of macrophage activation. Ann. Rev. Immunol. 2: 238-318.
Saklatvala, J., S.J. Sarsfeld, Y. Townsend. 1985. Pig interleukin-1. J. Exp. Med. 162: 1208-1222
Yang, R.D., L.L. Moldawer, A. Sakamoto, R.A. Keenan, D.E. Matthews, V.R. Young, R.W. Jr. Wannemacher, G.L. Blackburn, and B.R. Bistrian. 1983. Leukocyte endogenous mediator alters protein dynamics in the rat. Metabolism 32:654-660.
Dinarello, C. 1984. Interleukin-1. REv. Infect. Dis. 6:51-95.
Cerami, A., Y. Ykeda, N. LeTrang, P.J. Hotez, and B. Beutler. 1985. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immun. Lett. 11:273-177.
Lomedico, P.T., V. Gubler, C.P. Hellman, M. Dukovitch, J.G. Giri, Y-CE Pan, and K. Collier. 1984. Cloning and expression of murine interleukin-1 cDNA in E.co1i. Nature 312:456-462.
March, C.J., B. Mosley, A. Larsen, D.P. Cerretti, G. Braedt, V. Price, S. Gillis, C.S. Henney, S.R. Kronheim, K. Brabstein, P.J. Canlon, T.D. Hopp, and D. Cosenan. 1985. Cloning sequence, and expression of two distinct human interleukin-1 cDNAs, Nature 315:641-647.
Aueron, P.E., A.C. Webb, L.J. Rosenwasser, S.F. Mucci, A. Rich, S.M. Wolfe, and C.A. Dinarello. 1984. Nucleotide sequence of human monocyte Interleukin-1 precursor mRNA Proc. Natl. Acad. Sci. USA 81:7907-7911.
Wingfield, P., M. Payton, J. Tavernier, M. Barnes, A. Shaw, K. Rose, M.G. Simona, S. Demczuk, K. Williamson, and J.M. Dayer. 1986. Purification and characterization of human interleukin-1ß expressed in recombinant Escherichia coli. Eur. J. Biochem. 160:491-497.
Baracos, V.E., and A.L. Goldberg. 1986. Maintenance of normal length improves protein balance and energy status in isolated rate skeletal muscles. Am. J. Physiol. 251:C588-C596.
Tischler, M., M. Desautels, and A.L. Goldberg. 1982. Does leucine, leucycl tRNA or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle. J. Biol. Chem. 257:1613-1621.
Dinarello, C.A., G.H.A. Clowes Jr., A.H. Gordon, C.A. Saravis, and S.M. Wolff. 1984. Cleavage of human Interleukin-1: Isolation of a peptide from plasma of febrile humans and activated monocytes. J. Immunol. 133:1332-1338.
Beutler, B., and A. Cerami. 1986. Cachectin and tumor necrosis factor as two sites of the same biological coin. Nature 320:584-588.
Sobrado, J., L.L. Moldawer, C.A. Dinarello, G.L. Blackburn, and B.R. Bistrian. 1983. Effect of ibuprofen on fever and metabolic changes induced by leukocytic pyrogen (Interleukin-1) and endotoxin. Infect. Immun. 42:997-1005.
Tocco-Bradley, R., L.L. Mo1dawer, M. Georgieff, C.T. Jones, G.L. Blackburn, and B.R. Bistrian. 1986. Effects of recominant murine Interleukin-1 on protein dynamics in the rat. Proc. Soc. Exp. Bio1. Med. 182: 263-271
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Baracos, V.E. (1988). Role of Factors Derived from Activated Macrophages in Regulation of Muscle Protein Turnover. In: Hörl, W.H., Heidland, A. (eds) Proteases II. Advances in Experimental Medicine and Biology, vol 240. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1057-0_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1057-0_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8313-3
Online ISBN: 978-1-4613-1057-0
eBook Packages: Springer Book Archive